ENVB
Enveric Biosciences·NASDAQ
--
--(--)
--
--(--)
ENVB Filings
Filing Date
Form Description
Form Type
2026-03-27
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-27 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-27
Form 8-K - Current report
Key Events
2026-03-27 · Key Events
Form 8-K - Current report
2026-02-18
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-18 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-18
Form EFFECT - Notice of Effectiveness
2026-02-18 ·
Form EFFECT - Notice of Effectiveness
2026-02-11
Form D - Notice of Exempt Offering of Securities
2026-02-11 ·
Form D - Notice of Exempt Offering of Securities
2026-02-10
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-10 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-06
Form 8-K - Current report
Key Events
2026-02-06 · Key Events
Form 8-K - Current report
2026-02-06
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-06 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-04
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-04 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-02
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-02 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
